TGA Approval

DROSPIRENONE/ ETHINYLOESTRADIOL-GH TABLETS 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack (180562)

ARTG ID

180562

ARTG Name

DROSPIRENONE/ ETHINYLOESTRADIOL-GH TABLETS 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack

Sponsor

Lupin Australia Pty Limited

ARTG Date

January 20, 2012

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Lupin Australia Pty Limited

Sponsor Item Name

LUPIN AUSTRALIA PTY LIMITED

Active Ingredients

Ingredient Name

drospirenone

Ingredient Name

ethinylestradiol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

DROSPIRENONE/ ETHINYLOESTRADIOL-GH TABLETS 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack (180562) - TGA 批准文号 | MedPath

AI-Powered Research

Premium Access

DROSPIRENONE/ ETHINYLOESTRADIOL-GH TABLETS 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack (180562)

Sponsor Information

Active Ingredients

MedPath

Product

Company

Legal